放線菌の生産する新規デヒドロペプチダーゼ阻害物質に関する研究 by Hashimoto, Seiji










Studies on New Dehydropeptidase Inhibitors 
from Streptomyces 




the Faculty. of Agriculture 
in 
Fulfillment of the Requirements 
for the Degree 
of 
Doctor of Agriculture 












Studies on New Oehydropeptidase Inhibitors 
from Streptomyces 
Contents 
Introduction ... .. ..... . . ................. 1 
References 
Taxonomy, Fermentation, I solation, and 
Physico-chemical Properties ............. 10 







Chapter III Structure Determination of WS1358Al and 
WS1358Bl . ........... . ................ .. .. ~{0 
I I I -1 Determination of plane structure 
( ) 
III-2 














Biologi~al Properties of WS1358Al . ...... SO 
In vitro properties of WS1358Al 




Chemical Transformation and Total Synthesis 
of WS 1 3 58 A 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 3 
Chemical transformation 




Conclusion .............................. 81 
Acknowledgments .. . . .. ........ . ........................ 83 
( ii ) 
Chapter I Introduction 
Over the past 20 years , many antibiotics have been 
synthesized by using the penam and cephem structures. When 
it. was discovered, thienamycin was the first example of a 
novel, naturally occurring ~ -lactam with a carbapenem ring 
structure. Since then, other bicyclic and. more recently, 
monocyclic semisynthetic and synthetic compounds have been 
described. The carbapenem group of compounds differs from 
the penicillins (penams) in that the 1-sulfur atom is repla-
ced by carbon and there is a double bond at positions 2 to 3 
(Fig. 1). 
Carbapenems were discoverd almost simultaneously by 
workers at Beecham Research Laboratories and Merck Sharp & 
Dohme Research Laboratories. The former identified three 
compounds, MM4550, MM13902 and MM17880 from a culture of 
Streptomyces olivaceus 1 >. These compounds were designated 
olivanic acids. Merck Sharp & Dohme Research Laboratories 
isolated thienamycin from a culture of Streptomyces cattleya 
2) Since then, 40 or more compounds have been described. 
There is considerable information on a wide range of 
thienamycin derivatives. Thienamycin has a very broad anti-
bacterial spectrum, including P. aeruginosa. Members of the 
family Enterobacteriaceae including many isolates resistant 
to other ~ -l actams , S. aureus and Bacteroides fragilis are 
also suspectible to thjenamycin . However an early observa-
1 
Fig. 1. ~ -Lactam antibiotics produced by microorganisms. 
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tion 21 indicated the chemical .instability of this compound. 
Due to the chemical instabi 1 i ty of thienamycin, futher 
development of it has ceased and n search for chemically 
stable derivatives was undertaken, investig~ting several 
hundred analogs. N-Formimidoyl thienamycin (imipenem, Fig. 2) 
was finally selected for studies in humans. 
Imipenem has good stability to the ~ -lactamases from 
S. aureus, B. fragillis and Richmond and Sykes type Ia, m 
and rvc enzymes='>. The compound is also a potent inhibitor 
of t.ypA Ia and B. fragillis en7.ymes. Imipenem is active 
against strains possessing the constitutively produced P99 
cephalosporinases11 • 
The susceptibility of carbapenems to metabolic inacti-
vation in animals has been a major problem. Kropp et al. ~~ 
surveyed homogenates of different animal organs for enzyma-
tic inactivation of thienamycin. Significant rates of degra-
dation were found only in homogenates of the kidney, a find-
ing consistent with the conclusions of disposition studies. 
Loss of antibiotic activity in extracts was accompanied by 
extinction of the ultraviolet-absorbing chromophore of the 
antibiotic, a hallmark of scission of the ~ -lactam bond 
(Fi~ 3). The observation that the degrading enzyme was mem-
brane-associated and zinc-dependent lAd to a review of the 
distribution and properties of known renal metallopeptidase. 
Most similnr was the renal dipeptidase which had originally 
been designated dehydropeptidase-I by its discoverer Green-
stein61. The product of cnzyme-catalysed inactivation was 
3 
Fig.2. Structures of imip~nem and cilastatin. 
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proved identical by NMR and mass ~pectroscopy with thot 
~enerated by controlled acid nydrnlysJs nf the ~ -lActRm. 
()ehyctropept.iriase-I tt"lus acts as Anunpr-?c~denteri mammalion 
{3 -lactAmase upon t!"l.ienomycin antibiotir.:s, all the more re-
markable consirierin~ the stAbility of thien::tmycin etnd imipe-
nem toward classical bacterial {3 -lr.Ictamases. Conversely, 
the classical penicillins and c~pholcsporins. despite their 
sensit.ivity to bacterial 8 -l.~ctnma!';eS , show little or no 
detectable susceptibility to hydrolysis by dehyctropeptidase-
r. 
The enzyme responsibl~ for this inact. ivation has been 
thl!S shown to be a renal t.ubular hrush border dipeptidase 
(EC 3. 4. 13. 11), <iehyctropeptldasc-l (DHP). 
Following administration of radiolab~lled imipenem to 
the ra t. rabbit and more recently in _man. at least 90% of 
the administered radioactivity was found in the urine 
either as intact antibiotic or a fraction identical in its 
chromatographic mobility to the product of DHP catalysed 
hydrolysis DHP's role in metabolism readily explained the 
very low urinary recovery of N-acylat8d carbapenems of natu-
ral origin. since these ag~nts Are uniformly much more sus-
ceptible in vitro to DHP. Renal metabolism of imipenem in 
man might result in suboptimAl levels of antibiotic in the 
urinary tract, ~ven with dose regimens sufficient for the 
treatment of systemic infection. For example. in an indivi-
dual with A 10% urinary recovery, con.;.Pntrntions of imipenem 
in the urine would fall below any desired level approxima-
tely 3 h earlier than those achieved by another non-metabo-
lized antibiotic. 
There have been two.approaches to solve this problem. 
F~rst, there is the structural approach. Nonbasic acyl-
aminoalkyl-thio side chains at C-2 are less stable than 
other substituents. Appropriate alterations at this site 
provide relatively more stable compounds . Alteration at C-3 
in the PS series have been shown to affect the stability to 
the dehydropeptidase of rat kidneys. The ser.ond approach is 
to combine the DHP inhibitor with the antibiotic. The latter 
approach developed an inhibitor of DHP suitable for co-admi-
nistration with imipenem. 
In a directed search fo r potential inhibitors, compou-
nds resembling or containing the dehydropeptide bond were 
screened in vitro against DHP. Ben?.oyl-2-aminocrotonate was 
found to have moderate inhibitory activity. Systematic modi-
fication of this lead by Ashton et al. 71 resulted in the 
discovery of a class of 2,2-( + )-dimethylcyclopropylcarboxy-
2-amino-3-alkyl-(Z) - propenoates with the greater inhibitory 
activity against both porcine and human renal DHP. These 
inhibitors are competitive and reversible in their action 
and showed a high degree of specificity. For example, at 
concentration up to 1 mM (10 , 000 times their Ki versus DHP), 
llttle or no inhibition was detected with the following 
zinc-metallopeptidase: acylase-! (hog kidney), carboxypepti-
dase-A (bovine pancreas), carboxypeptidase-a (bovine pancre-
as) and angiotensin-converting enzyme (rat lung) . These com-
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pounds are also devoid of antimicrobial activity when tested 
at the highest concentrations likely to be achieved in ei-
ther blood or urine. Renal metabolism was inhibited for the 
longest duration by two analogues, tl1e octenoate (MK0789) 
and the L-cysteinyl-thio- hexenoate (ci lastatin, Fig. 2). 
The importance of having a metabolically stable compou-
nd is twofold. First, the urinary recovery and the levels in 
urine will be greater. Second, the nephrotoxic breakdown 
products of imipenem adminstered will be re1uced. 
The effect of co-administered cilastatin on the urinary 
recovery, plasma profile and renal clearence of imipenem was 
determined in animals~> and human 9 >. The anticipated efficacy 
of cilastatin was observed in all tests . The augmented pro-
tective effect of imipenem co-administered with cilastatin 
was also verified in the animal models of bacterial infec-
tion. Moreover, cilastatin co-administered with imipenem 
prevents the occur·rence of actue proximal tubular necrosis 
which is induced in rabbit kidney by an only imipenem admi-
nist.ration. 
A ratjonal e for the combination of imipenem with 
cilastatin can be compared with that for the two already 
established combination antimicrobials, trimethoprim/sulpha-
methoxazole and amoxicillin/clavulanate. In the latter two 
cases, both components are directed against bacterial meta-
bolic processes. Incremental benefit is achieved by mutual 
potentiation of antibacterial activity against that fraction 
of organisms insensitive to either component or by r estora-
7 
tion of activity against a fraction strains exhibiting pre-
existP.nt resistance to one of t.he components. In the present 
case, however, imipenem is the sole antimicrobial principle. 
Its breadth of spectrum, potency and lack of cross-resistan-
ce wjth other antibiotics leaves little that could be impro-
ved upon by a co-administered antimicrobial partner. Cila-
statin is instead directed to the control of antibiotic 
inactivation. This role of cilastatin is closely analoeous 
to that of carbidopa in the carbtdopa/levodopa combination. 
In both cases, the active ingredient is spared from univer-
sally present and undesirable metabolism and can achieve 
efficacy at a lower dose with attendant economic and safety 
benefits. 
The validity of DHP inhibitors in the combination with 
carbapenem prompted the auther to search new ones for deve-
loping carbapenem antibiotics. Many enzyme inhibitors have 
been found from the microbial origin. The author was also 
able to find new DHP inhibitors shown below from the fermen-
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Chapter II Taxonomy. Ferrnc->ntat.ion, Isolation 
and Physico-chemical Properties 
TT-l Taxonomic studies on the producing organism 
The producing organism, strain No. l35R, was isolated 
from a soil sample collected at Tochigi City, Tochigi Pre-
fP.cture. Japan. 
Morphological observ:::~tions were made with a light and a 
scanning electron microscope (Fig. 1) on cultures grown at 30 
t for 2 to 3 weeks on yeast extract -malt extract agar, 
oatmeal agar and inorganic salts - starch agar. The subst-
rate mycelia were well developed and brnnched without frag-
mentation. The aerial mycelia branched monopodially, and 
formed spjral, sometimes looped, spore chains with 10 to 50 
spore per chain. The spores had a smooth surface and were 
subglobose to oblong in shape with a size of 0. 5 to 0. 7 by 
0. 5 to 0. 9 ~m. These spore masses often appGared to coalesce 
in moist globules. Sclerotic granules. sporangia and zoo-
spores were not observed. The cultural characteristics of 
strain No. 1358 are summarized in Table 1. The aerial mass 
color was brownish grey to greyish brown. Reverse side of 
growth was yellowish white to greyish yellow. Melanoid and 
other soluble pigments were not produced. The physiological 
characteristics and utilization of carbon sources of strain 
No.l358 are summarized in Table 2 and 3. Hydrolized whole 
1 0 -
Fig. 1. Scanning electron microphotography 
of aerial mycelia of strain No. 1358. 
The bar represents 1 ~m. 
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Table I. Cultural characteristics of strain No. 1358. 
Medium Growth Aerial mycelium Reverse side of Soluble 
substrate mycelium pigments 
Yeast extract- mall Abundant White, brownish Grayish yellow (4B3) None 
extract agar gray (6D2), grayish 
brown (7F3) 
Oatmeal agar Moderate Grayish brown (5F3) . Yellowish white (3A2) None 
Inorganic salts- starch Abundant Brownish gray (7D-E2) Grayish yellow (4D3) None 
agar 
Glycerol- asparagine Abundant Brownish gray (6C2) Yellowish white (4A2) None 
agar 
Peptone- yeast Moderate None Light yellow (4A4-5) None 
...... 
extract- iron agar 
N Tyrosine agar Abundant Orange gray (5B2), Grayish orange (5B3) Scant, 
brownish gray (7E2) grayish orange 
Glucose- asparagine Abundant Brownish gray (6C-D2), · Yellowish white ( 4A2) None 
agar grayish brown (7F3) 
Nutrient agar Moderate None Pale yellow (3A3) None 
DENNEIT agar Abundant Dark brown (6F4) Pale yellow (3A3) None 
Sucrose- nitrate agar Abundant None Pale yellow (3A3) None 
Table 2. Physiological characteristics of strain No. 1358. 
Temperature range for growth · 
Optimum temperature for growth 
Liquefaction of gelatin 
Coagulation of milk 
Peptonization of milk 
Hydrolysis of starch 
Melanoid production 




































-:No growth, +:good growth. 
Table 4. Differences between strain No. 1358 and 
Streptomyces parvu/us IFO 13193. 
Temperature range 
for growth COC) 
NaCl tolerance (%) 
No. 1358 IFO 13193 
16-33 14-40 
2 10 
- 1 3 -
cell of str-ain No.l358 contajned the t.t.-riiaminoptmelic acid. 
Accor-dingly, the cell wRll of this str-ain is believed to be 
of type I. 
Based on the taxonomi~ pr-operties describe~ above, 
strain No. 1358 is ~onsider-ed t0 belong to the gP-nus Strepto-
mycP.s11 and to be a strain of the grey series of the Pr-id-
ham anrt Tresner grouping21 • Strain No. 1358 was compared with 
Streptomyces spec is des<'r ibed in 1 i teratures 3 _,,. As a 
result, it was founri that the strain proved to closely 
resemble Streptomyces parvullus IFO 13193 in detail. There, 
it was found that thA properties of hoth strains were almost 
identical except a few differences. Table 4 shows the diffe-
rences between two strains. These differences are not suffi-
cient to c0nsider that strain No. 1358 belongs to a distinct 
species. So , it is considered to be proper that strain No. 
1358 is a sub-species strain of S. parv~Jllus. Therefore, this 
strain was designated as S. parvullus subsp. tochigiensis No. 
1358. The strain has been deposited in Fermentation Research 
Institute,Agency of Industrial Science and TPchnology, Japan 
under the accession No. FERM BP-1638. 
II-2 Fermentation 
A typical fermentation profile for the production of 
WS1358 is shown in Fi~ 2. The prorluction of active compounds 
dur-ing the fermentation was monitor-ed by measuring the inhi-
14 -
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bitory activity against DHP and assPssed from the standard 
curve of the purified WS1358Al. The production as well as 
the cell growth was initiated on day 2 and rapidly reached 
a maximum of about 3. 7 ~g/ml on day 3. 
I I-3 Isolation 
Th~ procedures of the isolation are summar ized in Fig. 
3. Throughout these purific<'\tion procedures. the WS1358 
compounds were monitored by an analytical reverse-phase HPLC 
instead of enzyme assay. 
It is very difficult to isolate WS1358Al directly from 
the fermentation broth by means of conventional methods, 
because it is only produced in a small q ·uant i ty and has the 
same physico-chemic8.1 properties close to those of the impu-
rities. However, we discovered that WS1358Al can be reversi-
bly trAnsformed to the two compounds , designated A2 and A3, 
which are more lipophilic and more easily isolated from the 
fermentation broth than Al is . Making use of this chemical 
transformation to purify WS1358Al, we converted Al to A2 and 
A3 in the course of purification and finally converted the 
purified A3 to Al. More detailed mechanism of this chemical 
transformation will be described in the chapter V. 
The cultured broth was filtered with the aid of diato-
maceous earth. The filtrate (390 liters) was adjusted to pH 
10 with 6 N NaOH and allowed to stand for 2 hours at room 
1 6 -
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temperature (A2, A3 ~ Al conversion). The resultant precipi-
tate was filtered and discarded. The filtrate was passed 
through a column of Dowex 1X2 (Cl- type). The active princi-
ple was eluted with 0.2 M NaCl solution after washing the 
column with water and 0.1 M NaCl solution. The eluate was 
adjusted to pH 2 with 6 N HCl and adsorbed to activated 
carbon. The active principle was eluted with 25~ aqueous 
methnol containg 0. 5 N NH10H after washing the column with 
water and 25~ aqueous methanol. The eluate was concentrated 
in vacuo and adjusted to pH 2 with 6 N HCl. The rtesalted 
eluate was applied on a column of an adsorption resin Diaion 
SP-207 and developed with water. The fraction containing 
WS1358Al was eluted more slowly than the fraction containing 
WSl358Bl. 
WS1358A3 
The former fraction in the SP-207 column chromatography 
was concentrated in vacuo followed by the addition of an 
equal volume of 0.2 M NH1H2P01 buffer (pH 2. 3). The resul-
tant solution was passed through a column of Dowex 1X2 (Cl-
type) equilibrated with 0. 1 M NH1H1P04 buffer and eluted 
with the same buffer. The active fraction containing WS1358 
Al was concentrated in vacuo and freeze-dried (Al ~ A2 + A3 
conversion). The lyophilizate thus obtained was dissolved in 
deionized water. The solution was applied on a column of SP-
207 and developed with water. WS1358A2 and A3 could be sepa-
rated from each other in this column chromatography. The 
fraction containg WS1358A3 was neutralized with 6 N NaOH and 
1 8 -
applied on a column of Sephadex G-15. The Pluate was freeze-
dried to give a white powder of WS1358A3 (35. 4 mg). 
WS1358Al 
WS1358A3 {30.2 mg) was dissolved in 0. 5 N N~OH (3. 5 ml) 
and allowed to stand for 30 minutes at room temperature {A3~ 
Al conversion), then diluted with water after neutralization 
with 6 N HCl. The resultant solution was applied on a column 
of DEAE-Sephadex A-25 CC:l- type) and eluted with water, 0.1 
M NaCl and 0. 2 M NaCl solution. The active fraction was 
adjusted to pH 2 with 6 N HCl and concentrated in vacou, 
then applied on a column of SP-207 and developed with water. 
The eluate was neutralized with 1 N NaOH and f~eeze-dried to 
give a white powder of WS1358Al (14. 9 mg). 
WS135881 
The fraction containing WS135881 obtained by the 1st 
SP-207 column chromatography was neutralized with 1 N NaOH 
and concentrated in vacuo. The resultant solution was 
applied on a column of Cellulose CFll and ~ashed with 2-
propanol, then developed with 75~ aqueous 2-propanol . The 
active fraction was concentrated in vacuo and applied on a 
column of DEAE-Sephadex A-25 (Cl- type) . The active fraction 
was eluted with 0.2 M NaCl solution and concentrated in va-
cuo. The eluate was applied on a column of SP.phadex G-1.5 
equilibrated with water,then eluted with water. The desaJted 
eluate was concentrated in vacuo to give the residue . The 
residue was recrystallized from aqueous methanol to give a 
colorless powder of WS1358Bl (1. 3 g). 
1 D -
II -4 Physico-chemical properties 
Physico-chemical properties and spectr~l data of 
WS1358Al and 81 Na salts are summarized in Table 5. The two 
compounds a r e soluble in water, slightly soluble in methanol 
and insoluble in acetone, ethy acetate, chloroform and 
n- hexane. They give positive color reactions for ferric 
chloride. Ehrli ch, ninhydrin And iodine vapor reagents, but 
not for Dragendorff . Molish and cerium sulfate reagents. 
These data suggested that the compounds have N-hydroxyl 
group. TheIR, 1 H-NMR and 13 C-NMR spectra are shown in Fig. 
4, 5, 6, r especti vely. The structures of WS1358 Al and 81 
were deduced as shown below on the basis of the physico-
chemical and spectral data. Details of the structural eluci-














Table 5. Physico-chemical properties of WS1358A1 and Bl. 
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I I-5 Summary 
The author discovered potent DHP inhibitors, WS1358Al 
and Bl, produced by Streptomyces sp. In vitro inhibitory 
activities (IC5o value) of WS1358A1 and 81 against porcine 
renal DHP were 3 and 600 nM, respectively. They also showed 
no cytotoxicity to the cultured cells and no toxicity to 
experimental animals. 
In particular, WS1358Al has more potent inhibitory 
activity than cilastatin and may have a possibility to be 




The media and procedures us e d for cultural and physiolo-
gical characterization of strain No. l35R were describe d by 
Shirl ing and Gottlieb 11 1 • Eac h culture was incubated at 30t 
for 2 to 3 weeks befo r e observation. The temperature range 
for growth was determined 0n yeast extract -malt extract 
agar using a temperature gradient incubator (Advantec Toyo 
Co. ) . The color names used in these studies were based on 
the Methuen Handbook of Colour 9 1 • The chemical composition 
of the cell wall was analyzed by the methods described by 
Becker et al. 10 1 , and Lechevalicr and Lechevalier 111 • Uti-
lization of carbon sources was examined according to the 
method of Pridham and Gottlieb 121 • 
Fermentation 
A loopful of the slant culture of strain No. 1358 was 
inoculated to a 500 ml flask containig 160 ml of the seed 
medium composed of corn starch J. 0%, glycerol 1. 0%, 
glucose 0. 5%, cotton-seed flour 1. 0%, dried yeast 0 . 5%, 
corn steep liquor 0. 5% and CaCOJ 0. 2% (pH 6. 5). The flasks 
were shaken on a rotary shaker (220 rpm) for 3 days at 30t. 
A 200-liter jar fermentor containing 150 liters of produc-
tion medium composed of glucose 1. 0%, glycerol 2. 0%, 
cot ton-seed flour 1. 0%, soy bean mea 1 1. 0%, dried yeast 
0. 5% a~d CaCOJ 0. 3% (pH 7.0) was inoculated with 3 liters 
of the seed broth and cultured for 4 days at 30t, aerated at 
150 liters per minute and agitated at 250 rpm. 
Enzyme assay 
The prodution and initial purification of WS1358 
compounds were monitored with the enzyme assay to determine 
the inhibitory activity. Partially purified porcine renal 
DHP is able to hydrolyze the unsaturated dipeptide, glycyl-
dehydrophenylalanine (GDP) as substrate 13 l. The activity of 
the enzyme was determined by observing the decline in absor-
2 6 -
bance at 275 nm. Inhibitory effect of a compound on DHP 
activity was also measured in a method shown in Fig. 7. Inhi-
bition percent, I "· was calculated as follows, I " = ( E -
T )/E X 100, where E was DHP activity without the compound, 
Twas DHP ~ctivity with the compound. 
Materials 
Partial purification of DHP from porcine kidney of was 
carried out using procedures slightly different from previ-
ously reported method 1 ~ 1 • Details were described in the 
chapter IV. GDP was synthesized by the method previously 
described 1 ~ 1 • Cilastatin was purified from a comercially 
available drug, Zienam. 
2 7 -
Fig. 7. Assay method of dehydropeptidase activi t y. 
Sample or H20 (0. 025 ml) 
0. 2 ml of 0.05 M MOPS buffer (pH 7 . 0) 
0. 025 ml of DHP sol ution 
Preincubation at 37~ for 5 minutes r 1 m1 of 0. 1 mM GOP in 0. 05 M MOPS buffer 
Incubation a.t 37~ for 30 minutes 
r-- .1 m1 of 0 . 1 M EDTA 
Measurement of a bsorbance at 2 75 nm 
Inhibition (~) a (E-T)/E X tOO 
E; DHP activity with H1 0 
T; DHP activity with sample 
COOH 
Dehydrapeptide 
- 2 8 -
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Chapter III Structure Determination of WS1358Al 
and WS135881 
TII-1 Determination of plane structure 
WS1358A1 ( 1 ) was isolated as a colorless powder from 
the fermentation broth of Str~ptomyces sp. No. 1358: Na salt , 
c, H!,NO,Na2 (e l emental analysis); free acid, C,Ht, NO, (fast 
atom bombardment (FAB) - MS); (a Jo - 14. 0" (c 0. 9, HzO, Na 
salt). Fr om the same culture broth, WS135881 (2) was iso-
lated as a colorless powder : Na salt, CsH,NO,Na2 (elPmental 
analysis); free acid, CsH!lN07 (FAB-MS); (a )o+2. 5" Cc 1. 0, 
H~o. Na salt). 
7 CHa OH 
1 1 
COOH COOH 
HOOC 5 6CONHOH HOOC5 
6CONHOH 
1 2 
The 13 C NMR spectrum of 2 CD20, pD 7.0) revealed all 
the carbon signals, which were assignable to three carbonyls 
(6 185.3 (s, C-5), 178.2 (s, C-1), 173.6 (s, C-6)), one 
tertiary alcohol (6 82. 7 (s, C-2)), and two methylenes 0 
35. 6 (t, C-3) , 34. 8 (t, C- 4)). The proton signals cor res-
pending to the two methylenes were observed at o 2. 25-2. 11 
3 0 -
(4H) as multiplet in the 1 H NMR spectrum of 2 (DzO, pD 7. 0). 
The linkage of all the six carbons in 2 was determined by 
using a 20 INADEQUATE technique 1 >. r-evealing the carbon 
framework of 2 ;:iS depicted in Fig. 1. 
The remaining problem is to elucidate the position of 
the function containing nitrogen. As described in the pre-
ceding chapter, 2 showed a positive color reaction (purple) 
against ferric chloride, suggesting the presence of a hydro-
xamic acid function in 2. In the 1 3 C NMR spectrum, the 
carbonyl of a hydroxamic acid usually resonates at higher-
field region than that of the corresponding carboxylic 
acid·. Therefore, the C-6 signal at 6 173.6 (the highest-
field signal in the carbonyl region) was assigned to the 
hydroxamic carbonyl carbon. This was also corroborated 
by the mechanistic consideration in an alternative synthesis 
of this series of compounds as will be discussed in the 
chapter V. The structure of WS1358Bl was thus deduced to be 
2 without stereochemistry. 
The presumed structure of 2 was confirmed by a synthe-
sis as follows (Fig. 2). Compound 3. prepared by Michael 
condensation of methyl acrylate and dimethyl malonate, was 
* This was studied using model compounds: in the l 3 C NMR 
spectra (CD~OD), the carbonyl of 3-phenylpropionic acid 
resonated at 6 176. 7, while conver-sion to the corresponding 
hydroxamic acid shifted the resonance of the carbonyl up-
field to 6 171. 9. 
3 t -
Fig. l. The partial structur~ of 2 and its 13C N~R 
data (chemical shifts in ppm). 
0 
0 OH 
1 /c----c~5 --tHz--EHz--2c 178. z 
185.3 34.8 35.6 82. 0~--
11173.6 
0 
Fig. 2. Synthesis of WSI358AI and Bl racemates. 
3 R 1 =H R1 =CH3 4 R1 =H R1 =CH3 
5 R 1 = CH3 R1 = Et 6 R 1 =CH3 R1 =Et 
- 3 2 -
1, 2 
subjected to oxidation with benzoyl peroxide to give com-
pound 4. Treatment of 4 with hydroxylamine (2 equiv), 
followed by a sequence of purification pr0cesses described 
in the preceding paper provided 81 (2, racemate) as the Na 
salt. 
The Rtructure of WS1358Al (1) was deduced in a similar 
manner by analysis of its 1 3C NMR spectrum (D:!O, pD 7. 0), 
which showed seven carbon signals attributable to three 
carbonyls (5 184. 7 (s, C-5), 177. 7 (s, C-1), 173. 2 (s. C-
6)), one tertiary alcohol U 86. 0 (s, C-2)), one methylene 
(6 42.2 (t, C-4)), onemethine (6 38.9 (d, C-3)), andone 
methyl (o 15.8 (q, C- 7)). The methyl proton signal was 
observed at 6 0.82 (3H, d, J = 6. 5Hz) and the methylene and 
methine signals appeared at o 2. 18 OH, dd, J = 13. 5 and 3 
Hz), 1. 96 (lH, dd, J = 13. 5 and 11 Hz) and at 6 2. 77 (lH, m) 
in t.he 'H NMR spectrum CD20. pD7. 0) of 1. 
The carbon skeleton of A1 (1) was deduced to be the one 
depicted in Fig. 3 by the following NMR studies. The down-
field shifts observed for C-2, C-3 and C-4 (3 . 3, 3. 3 and 
7.4 ppm, respectively) of 1 as compared with the correspond-
ing carbon signals of 2 were attributable to a substitution 
effect of the methyl group21 , indicating that the carbon 
bearing the methyl group is ad,jacent to C-2 and C-4. This 
was corroborated by a COLOC experiment 31 , which showed that 
the methyl protons are coupled to C-2 and C-4, and further 
both methylene protons of the C-4 are coupled to the C-5 
carbonyl. These data supported the carbon framework depicted 
3 3 -
Fig. 3. The partial structure of 1 and its NMR data 
(chemical shifts in ppm and 1 H·13C relationships). 




c' 4 ' 2 / 1 77. 7 
- c c c 184~ 42.2 38.9 86.~~-
\ 173.2 
H H 
1. 96 2.77 0 
- 34 -
in Fig. 3. As in the case of WS135881. the highest-fi e ld 
signal (C-6, 6 173. 2) of the three carbonyls was assignable 
to the hydroxamic acid and, consequently, the structure of 
Al was proposed to be 1 without stereochemist-ry. 
The presumed structure of 1 was ascertained by a 
sequence of synthetic reactions similAr to that used for 81 
CFig. 2). Michael condensation of ethyl crotonate and di-
ethyl malonate gave compound 5, which was similarly sub-
jected to oxidation with benzoyl peroxide to yield benzonate 
6 . Treatment of 6 with hydroxylamine and subsequent purifi-
cation afforded WS1358A1 (1, racemate) as a major product 
together with a minor diastereoisomer in a ratio of about 
3:2. 
The structures of WS1358A1 and 81 were thus established 
as being 1 and 2, respectively. As shown in Table 1, the 
biological activities of these synthetic compounds were 
found to be about half of those of the corresponding natural 
products, respectively. 
Table 1. IC,0 of synthetic and natural WS1358 com-












III-2 Determination of absolute structure 
WS1358Al (1) is a new, potent dehydropeptidase (DHP) 
inhibitor isolated from a Streptomyces. In the previous 
section, we described the structure elucidation and the 
synthesis (as a racemate form) of this substance. The 
st~reochemistry of this substance has remained unsolved, 
however. In this section, the author will describe an asym-
metric synthesis of WS1358Al, which leads to a conclusion 
that the natural product possesses the R absolute configu-
ration at C-3, although the configuration at C-2 still re-
mains undetermined. WS1358Al exists as a mixture of the 
diastereoisomers la and lb at C-2 probably through compounds 
7 and 8 . It is unclear which isomer is stable and predomi-













- 3 6 -
As a starting material for the synthesis (Fig.4) of the 
optically active WS1~58A1, we chose the half ester of 
~ -methylglutaric acid. The R-(+) enantiomer 10 of this 
half ester was obtained by resolution using cinchonimide 
according to the method described in the literature~>. 
Reduction of 10 using diborane gave alcohol 11 in 94. 3% 
yield. which, after protection with the t-butyl-dimethyl 
silyl group (12, 77.6%), was allowed to react with dimethyl 
carbonate in the presence of lithium diisopropylamide to 
afford malonate 13 in 45. 6% yield. Jones oxidation of this 
product yielded carboxylic acid 14 (66. 7%), which was then 
subjec~ed to chlorination with hypochlorite to provide chlo-
ride 15 in 68.0% yield. The carboxylic acid function in 15 
was next led to the active ester by using N-hydroxysuccin-
imide and then allowed to react with hydroxylamine to yield 
a mixture of hydroxamic acid 16 and its cyclized product 17 
(57. 5%). Silica g~l column chromatography separated 
N-hydroxyglutarimide 17, although hydroxamic acid 16 was 
unable to be isolated as a pure form. The crude mixture of 
16 and 17 was finally treated with 1 N NaOH and purified by 
column chromatography on Diaion SP-207 to provide WS1358Al 
in 55.8% yield. The product was found to be amixture of the 
diastereoisomers la and lb as shown on HPLC (Fig. 5). The 
ratio of these isomers was about 7:2, although it was ambi-
guous which was the major isomer in this mixture of la and 
lb. 
The synthetic product 1 was identified with the natural 
3 7 -
Fig. 4. Asymmetr ic synthesis of WS1358A l. 
~ CH, H 
Hooc coacH3 ___ HanaacH, 
10 11 12 
n:





~coacH, ____ ~ 
HOOC COOCHa 
13 14 
CH3 ~ Cl CH3 ;H Cl CH_3· j; Cl N COOCH_a_· -~ (YcoacH, acoocH,_· -~ 
HOOC COOCH, HOHNOC COOCH, + 0 7 O 1 
15 16 OH 
17 
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product on HPLC. The inhibitory activity of this synthetic 
product against renal DHP was 0. 88 ng/ml in IC!; 0 (the natu-
ral product, 0. 61 ng/ml). 
Fig. 5. HPLC analysis of asymmetrically synthesized 
WS1358A1 
A 15-cm TSK gel ODS 80TM column was used with 
a mobile phase consisting of 0. 2 M NH~HzPO~ (pH 4) 
containing 1 mM Bu~NOH. The flow rate was 1 ml/ 
minute and solutes were detected by UV (210 nm). 
The retention times of A1 and A1' were 7. 15 and 
8. 13 minutes, respect.i vely. 
3 9 -
III-3 Summary 
The structures of WS1358Al and 81 , new dehydropeptidase 
inhibitors isolated from Streptomyces parvul us subsp. tochi-
giensis No. 1358, have been established to be 2-hydroxy-2-
hydroxyaminocarbonyl-3-methylglutaric acid and 2-hydroxy-2-
hydroxyaminocarbonylglutaric acid (2), respectively, without 
streochemistry on the basis of spectroscopic evidence and 
synthes i s of the racemates . 
The aymmmetric synthesis of WS1358Al led to a conclusion 
that the natural product possesses the R absolute configura-





IR spectra were recorded on a Jasco A-102 spectrometer. 
1 H and 13 C NMR spectra were measured on a Bruker AM400 spec-
trometer. MS were determined with a VG ZAB-SE spectrometer. 
Optical rotations were measured on a Jasco DIP-400 polarj-
meter. Analytical HPLC was performed on a Hitachi 655 liquid 
chromatograph using a YMC ODS-5 column (4. 6 X 250 mm) and 
preparative HPLC was carried out using a YMC ODS-5 column 
( 2 0 X 2 50 mm) . 
WS 13 58 A l (1) 
For isolation of WS1358Al. see chapter II: Na salt, (a)u 
-14. oo (c 0. 9 , H2 0); IR (KBr) em-• 1660, 1580; 1 H NMR (0 2 0) 
6 2. 77 (lH, m), 2 . 18 (lH, dd, J = 13.5 and 3Hz), 1. 96 (HI, 
dd, ,J = 13.5 and 11 Hz), 0. 82 (3H, d, J = 6. 5 Hz); 13 C NMR 
(D'l O) 6 184.7 (s), 177.7 (s), 173.2 (s), 86.0 (s), 42 . 2 (t), 
38.9 (d), 15.8 (q); Anal Calcd.for C7H!) NO,Naz·H:t0; C 29.69, 
H 3.92, N 4.95, Na 16.24; Found, C 30 . 05, H 3.84, N 4.84, 
Na 15.89. Free acid, FAB-MS m/z 222 (M.+1); 1 H NMR (Dz0-H 2 0) 
6 2. 89 (lH, m), 2. 39 (lH, dd, J = 15 and 3. 5 Hz), 2. 23 (lH. 
dd, .J = 1 5 and 10 Hz), 0. 95 ( 3H, d, J = 6. 5 Hz) ; 1 3 C NMR 
(0 2 0-H 2 0) 6 182.2 (s), 177.4 (s). 173.0 (s), 85.8 (s), 40.S 
(t), 38.5 (d), 15.9 (q). 
WS l 3 58 B 1 ( 2) 
For isolation of WSl35881, see chapter I I: Na salt, (a lo 
+2.5° (c 1.0, HzO); IR (KBr) cm- 1 1660 , 1620, 1580; 1 H NMR 
(0 2 0) 6 2.25-2.11 (4H, m); 13 CNMR (0?.0) 6185.3 (s), 178.2 
( s ) • 1 7 3. 6 ( s ) , 8 2. 7 ( s ) , 3 5 . 6 ( t ) , 3 4. 8 ( t ) ; An a 1 Ca 1 c d for 
C6 H7 N01Na 2 · H2 0; C 26. 78, H 3. 37, N 5. 20, Na 17. 08; Found. 
C 26. 44, H 3. 28, N 5. 10, Na 16. 88. Free acid, FAB-MS m/z 208 
(M.+1); 13 C NMR {DzO) 6 180.3 (s), 175.9 (s), 171.4 (s), 
81.4 (S) , 34.0 (t), 31.2 (t). 
Dimethyl 2-(Methoxycarbonyl)glutarate (3) 
- 4 l -
A solution of dimethyl malonate (13. 2 g, 0.1 mol) in 
benzene (~0 ml) was added to a suspension of sodium hydride 
(60% dispersion in mineral oil, 400 mg, 0. 01 mol) in b e nzene 
(50 ml) at Ot under an atmosphere of nitrogen. To this mix-
... 
ture a solution of methyl acrylate (8. 6 g, 0. 1 mol) in ben-
zene (30 ml) was added and the mixture was stirred at BOt 
for 1 hour. The re~ction mixture was cooled to room tempera-
ture poured into ice water, and extracted with ether. The 
extract was washed with water, dried over MgS04 and concent-
rated to give 3 as an oil (19. 4 g): electron impact (EI)-MS, 
m/z 218 (M•); 1 H NMR <CDC1:~) c 3. 73 (6H, s). 3. 69 (3H, s), 
3. 51 (lH, t, .] =7Hz) , 2. 5- 2. 2 (4H, m). 
Dimethyl 2-Benzoyloxy-2-(methoxycarbonyl)glutarate (4) 
A solution of 3 (2. 18 g, 10 mmol) in benzene (30 ml) 
wns added to a suspension of sodium hydride (60~ dispersion 
in mineral oil, 400 mg, 10 mmol) in benzene (50 ml) under an 
atmosphere of nitrogen. The mixture was refluxed for 1 hour, 
during whi c h the mixture became clear, and then cooled to 
room temperature. To this mixture a solution of benzoyl per-
oxide (1. 82 g, 7. 5 mmol) in benzene(30 ml) was added drop-
wise under ice-bath cooling and the mixture was stirred at 
room temperature for 15 hours. The reaction mixture was 
poured into ice water and extracted with ether. The extract 
was washed with water, dried over MgS04 and evaporated to 
give an oil (3. 85 g), which was purified by chromatography 
on silica gel, eluting with 20~ ethyl acetate in hexane. 
The fractions containing the desired product were combined 
and concentrated to give 4 as an oil (1. 83 g): FAB-MS, m/z 
339 (M.+1); 1 H NMR (CDClJ) o 8.09 (2H, br d, J = 8 Hz), 
7. 61 (lH, br t., J =8Hz) , 7. 47 (2H, br t, J =8Hz), 3. 84 
(6H, s), 3. 64 (3H, s), 2. 74 (2H, t, J = 7 Hz), 2. 49 (2.H, t, 
J = 7 Hz.). 
WS135881 (2, racemate) 
Hydroxylamine hydrochloride (139 mg, 2 mmol) was dis-
solved in 50~ aqueous methanol (0.8 ml) and 10 N NaOH (0.4 
- 1\2 -
ml, 4 mmol) was added. To this mixture a solution of 4 (338 
mg, 1 mmol) in methanol (2 ml) was added and the mixture was 
stirred at room temperature for 3 hours. The reaction mix-
ture, after being acidified with 1 N HCl to pH 2, was washed 
with ethyl acetate. The aqueous solution was neutralized 
with 1 N NaOH and concentrated to remove the organic sol-
vents. The resulting aqueous layer was passed through a 
column of Dowex 50WX2 (H•, 30 ml) and eluted with water. The 
eluate was lyophilized to give a powder (435 mg), which w~s 
purified by preparative HPLC on YMC ODS-5 eluting with 0. 1~ 
TFA in water. The fraction containing the product corres-
ponding to WS135883 (equivalent to WS1358A3) was collected 
and lyophilized to give a powder (60 mg), which was treated 
with 0.1 N NaOH (60 ml) for 2 hours and neutralized to pH 7 
with Dowex 50WX2 (H.). The solution was lyophilized to give 
WS1358Bl (2, racemate, 52 mg). This synthetic product was 
physically identical with the natural 81 in all respects 
except for optical rotation. 
Diethyl 2-(Ethoxycarbonyl)-3-methylglutarate (5) 
Compound 5 was prepared from diethyl malonate (16 g, 
0. 1 mmol) and ethyl crotonate (11. 4 g, 0. 1 mmol) in a manner 
similar to that for 3: yield 25. l g (oil); EI-MS, m/z 274 
{M •); tH NMR (CDCl:t) 6 4.27-4.09 (6H, m), 3.40 (lH, d, J = 
7 Hz), 2. 75 (lH, m), 2. 55 OH, dd, J = ln and 5 tiz)·, 2. 30 
(lH. dd, J = 16 and 8. 5 Hz), 1. 32-1. 22 (9H, m), 1. 08 (3H, d, 
J = 7 Hz). 
Diethyl 2-Benzoyloxy-2-(ethoxycarbonyl)-3-methylgluta-
rate (6) 
Compound 6 was prepared from 5 (274 mg, 1 mmol) in a 
manner similar to that for 4: yield 250 mg; EI-MS, m/z 394 
(M•); 1 H NMR (CDC1 3 ) 6 8.08 (2H, m), 7.67-7.42 (3H, m), 4 . 37 
-4.23 (4H, m), 4.17 (2H, q, J = 7 Hz), 3. 05 (lH, m), 2. 81 
(lH, dd, J = 16 and 3. 5 Hz), 2. 32 (lH, dd, J = 16 and 10 Hz) 
l. 34-1. 23 (9H, m), 1. 19 (3H, d, J = 7 Hz). 
- 4 3 -
WS 1358Al ( 1, racemate) 
Compound 1 was prepared from 6 (394 mg, 1 mmol) in a 
manner similar to that for 2 (racemate). The reaction mix-
ture, after being acidified with 1 N HCl, was washed with 
ether. The aqueous layer was neutralized with 1 N NaOH and 
evaporated to remove the organic solvents. The resulting 
aqueous solution was lyophilized and the residue was puri-
fied by chromatography on Oiaion SP-207 (20 ml), eluting 
with water to give a product corresponding to WSl358A3. This 
product was treated with 0. 5 N NaOH for 2 hours and neutra-
lized to pH 7 with Oowex 50WX2 (H•). The solution was lyo-
philized to give WS1358A1 (1, racemate , Na salt, 15 mg). 
This synthetic product was physically identical with the 
natural one in all respects except for optical rotation. 
On purification by the Oiaion SP-207 chromatography, 
another product corresponding to A3' (a diastereoisomer of 
A3) was also obtained, which was similarly treated with 0. 5 
N NaOH and neutralized to pH 6. 5. The solution was lyophi-
lized to give a diastereoisomer (racemate, Na salt, 10 mg) 
of A1 : 1 H NMR (0::0) 6 2. 76 (lH, m}, 2. 08 (lH, dd, J = 14 
and3Hz), 1.99 (lH, dd, J=14andl1Hz), 0.87 (3H, d, J= 
6.5 Hz); 13 C NMR (0::0) 6 184.5 Cs), 177.6 (s), t73.2 (s), 
86.0 (s), 41.9 (t), 38.9 (d), 16.0 (q). 
Methyl hydrogen @ -methylglutarate (9) 
3-Methylglutaric anhydride (33. 1 g, 0. 259 mol) was 
dissolved in anhydrous methanol (10 . 48 mJ, 0. 259 mol). The 
solution was stirred at 80~ for 4 hours under a nitrogen 
atomosphere . After cooling overnight, the solution was 
distilled under a reduced pressure to give methyl hydrogen 
f3 -methylgl utarate (9, 37. 4 g, 90!)6) : b. p. 115-118~/1. 8 
mmHg. 
R-(+)-Methyl hydrogen @ -methylglutarate (10) 
To a solution of 9 (59. 6 g, 0 . 37 mol) in water (590 ml) 
and methanol (83 ml) was gradually added cinchonidine (110 
g, 0. 37 mol). The solution was warmed at 80~ for 5 minutes 
- 4 4 --
and f i 1 tered. After standing at 5t: overnight, the crystal 
was filtered and successively recrystatized from 4~ aqueous 
methanol (550 ml) and water (367 ml) to give cinchonidine 
salt of 9 (33.8 g): (a)~ 1 -86° (c 4 . 4, methanol). The cin-
chonidine salt of 9 (33.8 g) was dissolved in hot water (200 
ml) and instantly cooled. To the cooled solutjon was added 
2 N HCl (200 ml) at Ot. The crystalizect half ester was ext-
racted with ether. The ether layer was washed with water, 
dried over MgS01 and concentrated to dryness under a reduced 
pressure to give R-(+)-methyl hydrogen ~ -methylglutarate 
(10, 12.35 g): (l)~ 0 +0.6° (c 100, homogeneous). 
Methyl S-Hydroxy-(3R)-methylpentanoate (11) 
To a solution of R-(+)-methyl hydrogen ~ -methylgluta-
rate (10, 9. 6 g, 0. 06 mol) in distilled anhydrous THF (60 
ml) was gradually added a solution of 1 M diborane in THF 
(66 ml, 0 . 066 mol) at -17'C with stirring under a nitrogen 
atomosphere. The mixture was successively stirred at -17t 
for an hour and at room temperature for 4 hours. After being 
cooled to Ot and added water (60 ml), the reaction mixture 
was evaporated in vacuo to remove THF. The resultant aqueous 
solution was extracted with ethyl acetate. After being suc-
cessively washed with diluted HCl and NaHCOa solution and 
dried over Mgso~. the ethyl acetate layer was concentrated 
to give methyl 5-hydroxy-(3R)-methylpentanoate (11, 8. 26 
g , 94.3~): FAB-MS; m/z 147 (M++l), (a)5° +2.5° (c 1, metha-
nol). 1 H-NMR (200 MHz, CDCl:~); o 3. 68 (3H, s), 3. 68 (2H, t, 
J = 7 Hz) , 2. 4 to 2. 05 (3H, m), 1. 70 ( 1H, brs, OH), 1. 55 
( 2H, m), 0. 97 ( 3H, d, J = 7 Hz). 
Methyl 5-t-Butyldimethylsiloxy-(3R)-methylpentano-
ate (12) 
To a solution of 11 (7 g, 48 mmol) in DMF (450 ml) was 
added imjdazole (8. 16 g, 57. 6 mmol) and t-butyldimethyl-
silylchloride (8.68 g, 57.6 mmol) at Ot under a nitrogen 
atomosphere. After stirring at room temperature overnight, 
the solution was concentrated under a reduced pressure to 
-- 4 5 -
give the oily residue, which was dissolved in ether . After 
being washed with water and dried over MgS01, the ether 
solution was concentrated under a reduced pressure to give 
methyl 5-t-butyldimethylsiloxy-(3R)-methylpentanoate (12, 
9. 67 g, 77. 6%): FAB-MS m/z 261 (M.+l), (a )~ 0 +2. 1 o (c 1, 
CHCl:tl, 1 H-NMR (200 MHz, CDC!:~) o 3. 65 (3H, s), 3. 63 (2H, 
t, J = 7 Hz), 2. 42 to 2. 0 (3H, m), 1. 65 to 1. 32 (2H, m), 
0. 95 (3H, d, J =7Hz), 0. 88 (6H, s), 0. 05 (9H, s). 
Methyl 5-t-Butyldimethylsiloxy-2-carbomethoxy-(3R)-
methylpentanoate (13) 
A solution of n-butyllithium in hexane (1. 6 M, 15 ml, 
24 mmol) was added dropwise to a solution of diisopropyl-
amine (2. 42 g, 24 mmol) in THF (100 ml) at -17t with stir-
ring under a nitrogen atomosphere. After stirring at the 
same temperature for 15 minutes, a solution of 12 (5. 2 g, 
20 mmol) in THF (40 ml) was added dropwisc to the mixture. 
After stirring at -17'C for additional 10 minutes, dimethyl 
carbonate (3. 6 g, 40 mmol) was added dropwise to the mix-
ture. After standing to room temperature, the mixture was 
stirred for 5 hours under a nitrogen atomosphere . The reac-
tion mixture was poured into ice-water and extracted with 
ether. The ether layer was wa shed with water, dried over 
MgS04 , and then concentrated to dryness under a reduced pre-
ssure to give a residue (6 g). The residue was purified by 
column chromatography on sil.ica gel, eluted with ethyl ace-
tate-hexane (1:19) to afford methyl 5-t-butyldimethylsiloxy-
2-carbomethoxy- (3R) -me thy lpentanoa te ( 13, 2. 9 g, 45. 6%) as 
an oil: FAB-MS, m/z 319 (M.+1), (a )~ 0 -4. oo (c 1, CHCl:J), 
1 H-NMR (200 MHz, CDCl:~) 6 3. 73 (6H, s), 3. 68 (2H, m), 3. 37 
(lH, d, J = 8. 5 Hz), 2. 4 (lH, m), 1. 74 to 1. 38 (2H, m), 
1.02 (3H, d, J = 7 Hz), 0.87 (6H, s), 0 . 05 (9H, s). 
4,4-Dimethoxycarbonyl-(3R)-methylbutyric Acid (14) 
To a solution of 13 (1.4 g, 4.4 mmol) in acetone (17 
ml) was added dropwise Jone's reagent (3 ml> at Ot with 
stirring, followed by successive stirring at O'C for 2 hours 
- tl 6 -
and at ~oom temperature for 2 hours . The reaction mixture 
was pou r ed into water and extracted with ether. The ether 
layer was washed with water and dried over MgS04. Removal of 
the solvent under a reduced pressure gave an oily residue 
(1 . 28 g), which was purified by column chromatography on 
silica gel, eluted with ethyl acetate-CHCla (1:4) to afford 
4 , 4 - dimethoxycarbonyl-(3R)-methylbutyric acid (14, 640 mg, 
66. 7%)as an oil: FAB- MS , m/z 219 (M'"+l), (II )G0 -8. oo (c 1, 
methanol), 'H-NMR (200 MHz, COCl:t) o 10. l (lH, br), 3 . 75 (6H 
, s), 3. 50 (lH, d, .J = 7 Hz), 2. 75 (lH, m), 2 . 62 (lH, dd, .] = 
16 and 5 Hz) , 2. 40 (lH, dd, J = 16 and 8 Hz), 1. 12 (3H, d , 
J = 7 Hz). 
4-Chloro- 4,4-dimethoxycarbonyl - (3R)-methylbutyric 
Acid (15) 
To a solution of 14 (640 mg, 2. 94 mmol) in water (10 
ml) was added dropwise a solution of NaOCt (available chro-
rine : minimum 5%, 4.9 ml) during a 20 minutes period while 
the pH was kP.pt 7 to 8 with 2 N HCl. After stirring at room 
temperature for an hour, the reaction mixture -was acidified 
to pH 2 by addition of 2 N HCl and then extracted with ether 
The ether extract was dried over MgSO~ and evaporated under 
a reduced pressure to give a residue (775 mg), which was 
purified by column chromatography on silica gel, eluted with 
methanol-CHCla (3:97) to afford 4-chtoro-4, 4-dimethoxycarbo-
nyl-(3R)-methylbutyric acid (15, 504 mg, 68%) as an o.il : 
(a )G 0 +0. 67° (c 1. 2 , methanol), 'H-NMR (200 MHz, CDCld o 
9. 2 (lH, br), 3. 8 (6H, s) , 3. l (lH, m), 2. 76 (lH, dd, J = 16 
and 2Hz)), 2. 26 (lH, dd, J = 16 and 10Hz), 1. 05(3H, d, J = 
7 Hz). 
Dimethyl 2-Chloro-2-((2-hydroxycarbamoyl-(lR)-methyl) 
ethyl)malonate (16) and Methyl 3-Chloro-hydroxy-(4R)-methyl-
2.6-dioxo-3-piperidinecarboxylate (17) 
To a solution of 15 (504 mg, 2 mmol) in CHzCh (10 ml) 
was added N-hydroxysuccinimide (230 mg, 2 mmol) , and the 
mi x ture was stirred at room temperature for an hour. To 
4 7 -
the resulting solution was added dicyclohexylcarbodiimide 
(412 mg, 2 mmol) at Ot and the mixture w~s successively sti-
rred at Ot for 5 minutes and at room temperature for 6 hours 
The reaction mixture was filtered, and filtrate was concent-
rated to dryness under a reduced pr~ssur~ to give N-hydroxy-
succinimide ester of 15 (700 mg) as a crude product . To a 
solution of hydroxylamine hydrochloride (167 mg, 2. 4 mmol) 
in water (?. ml) was added 1 N NaOH (3 ml, 3 mmol) at Ot with 
stirring. The resttlting solution was add~d dropwise to a 
solution of 4-chloro-4, 4-dimethoxycarbonyl-(3R)-methylbuty-
ric acid succinimide ester (700 mg) in ethanol (5 ml) at Ot. 
The mixture was successively stirred at room temperature 
overnight and at 80t for 2 hours. The reaction mixt11re was 
acidified to pH 2 with 1 N HCl and then extracted with ethyl 
acetate. The ethyl acetate extract was washed with water, 
dried over MgS01 and concentrated to dryness under a reduced 
pressure to give a residue (477 mg), which was purified by 
column chromatography on siljca gel, eluted with methanol-
CHCl:l (1:19) to afford a mixture of 16 and 17 (250 mg), 17 
( 145 mg): FAB-MS, m/z 240; 241 (M .. -H 2 O+Na), (a)~:! -13. so (c 
1, methanol), 'H-NMR (200 MHz. CDCl3) 6 3 . 88 (3H, s), 3.10 
(lH, m), 2. 82 (2H, m), 1 . 05 (3H, d, J = 7 Hz). 
2-Hydroxy-2-(hydroxycarbamoyl)-(3R)-methylglutaric 
A c i d ( WS 13 58 A 1 , 1 a) 
To a mixture of 16 and 17 (27 mg) was added 1 N NaOH (1 
ml), and the mixture was stirred at room temperature for 2 
hours. The reaction mixture was concentrated to dryness 
under a reduced pressure to give a product which contained 
WS1358Al (la) and its epimer, AI' (lb)at a ratio of 7:2. The 
'H-NMR spectrum and the retention time on HPLC of the syn-
thetic WS1358Al was consistent with those of natural 
WS1358Al. 
Biological evaluation 
Inhibitory activity (!Cso) of the synthetic compounds 
against porcine DHP was measured by the method described in 
the preceding chapter. 
- 4 8 -
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Chapter IV Biological Properties of WS1358Al 
IV-1 In vitro properties of WS1358Al 
WS1358Al and Bl were found to inhibit renal DHP from 
several species of animal as shown in Table 1. Especially, 
WS1358Al was more potent than cilastatin against all of the 
DHPs tested. In spite of their potent inhjbitory activity 
against DHP, WS1358Al and Bl did not inhibit carboxypepti-
dase A <CPase A) and leucineaminopeptidase (LAP) at a con-
centration of 100 -M. Therefore, WS1358 compounds were spe-
cific inhibitors against DHP. 
It was necessary to purify porcine renal DHP in order 
to examine the inhibitory mechanism of WS1358Al against this 
enzyme. In our procedure of purification, the steps of 
acetone precipitation, extensive washing with buffer and 
isoelectric precipitation previously reported have been 
eliminated to save labor and time . 
A summary of the typical purification is shown in Table 
2. From 94 g of porcine kidney cortex, 7 . 8 g of protein 
homogenate was obtained. The complete purification from this 
homogenate yielded 0. 6 mg of DHP which was apparently homo-
genous and had a molecular weight of about 50, 000 as judged 
by the SDS-polyacrylamide gel electrophoresis (data not 
shown). The over-all purification produced an enzyme appro-
ximately 1,800 times more active than the starting homoge-
nate. 
50 -
Table 1. IC,0 values of WS1358Al, B 1 and cilastatin 
against various peptidases. 
IC,0 (.uM) 
Peptidase 
AI Bl Cilastatin 
Renal DHP: 
Porcine 0.003 0.60 0.13 
Rabbit 0.04 2.7 0.075 
Mouse 0.01 1.6 0.25 
Rat 0.008 1.1 0.20 
CPase A > 102 > 102 > 102 
LAP > 102 > 102 > 102 
Enzymes were assayed using synthetic peptides as 
substrate. Enzyme activity was determined by measuring 
the decline of absorbance in the presence or the absence 
of an inhibitor. Inhibition percent W;lS calculated as 
described in the text. 
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Table 2. Purification of porcine renal dehydropeptidase. 
Total Total Activity Specific Purification 
Fraction protein activity• recovered activity (fold) (mg) (u)' (%) (u/mg) 
Homogenate 7,800 78 100 0.010 I 
Solubilized 2,688 97 124 0.036 3.6 
50-70% 
(NH4hS04 128 53.4 69 0.42 42 
()1 HPLC 12.2 22.6 29 1.8 180 
N Affinity 0.6 11.0 14 18.3 1,830 
chromatography 
• All fractions were assayed using 50 JlM GDP as substrate in 25 mM Tris-HCI buffer (pH 7.7) . 
Before measuring the kinetic parameters for enzyme-
cataly7.ed hydrolysis, a linearity between the purified 
enzyme concentration and enzyme activity against GDP was 
established over thA enzyme concentration range of 0. 05 
through 10 pg/ml. The kinetic parameters were then deter-
mined for GOP and imipenem in the absence or the presence of 
inhibitor, using the standard graphical technique of 
Lineweaver-Burk. Typical reciproca l plots for GOP and imipe-
nem are shown in Fig. 1. The following kinetic parameters of 
the purified enzyme could be calculated for the two subst-
rates GOP (Km = 0.3 mM, Vm•x = 800 ~mol/min per mg) and 
imipenem (Km = 7. 7 mM, Vmax = 23 ~mol/min per mg). 
WS1358A1 as well as cilastatin showed a competitive 
inhibition and the inhibition constants for WS1358A1 using 
GOP and imi penem as substrateR are K;, 2 X 1 o- 9 , 1. 6 X 1 o- 7 
M, respectively. The inhibition constants for WS1358A1 
compared with those of cilastatin are listed in Table 3. 
IV-2 In vivo properties of WS1358Al 
As shown in Table 4, the mean urinary recovery percents 
of imipenem intraveneouly administrated to mice at a dose 
of 1 mg/kg without DHP inhibitor were 44. 1%. However, when 
WS1358A1 was co-administrated at a dose of 1 mg/kg with 
imipenem (1:1), the urine recovery percents increased up to 




Fig. L Lineweaver-Durie plot of porcine renal dehydropeptidase-cntalyzed hydrolysis in the presence or 
absence of WS 1358A I. 
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The DHP-cnlalyzed hydrolysis rates were measured at 37°C in 25 mM Tris-HCl buffer (pH 7.7). The 
enzyme was mixed with an inhibitor and pre-warmed nl 37°C for 1 minute before adding the substrate. 
Velocity is expressed ns pmol/minute. Each point shows the mean of three to four determinations. 










Experimental conditions were the same as in Fig. I. 
The concentration tested for Ki determination of 
cilastatin was 0.26 pM. 
Table 4. Urinary recovery ofimipenem administrated to 



















The quantity of antibiotic excreted in urine within 4 
hours after the administration was measured by means 
of a bioassay. 
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cantly augmented at the combination ratios of WS1358A1 
versus the antibiotic within a range of 0. 5:1 to 2:1 by 
weight. A similar effect was observed when cilastatin was 
used as inhibitor in place of WS1358A1. Therefore, the 
effect of WS1358A1 in mice on urinary recovery of imipenem 
resembles that of cilastatin when co-administrated with 
imipenem to human volunteers'>. 
Although carbapenem antibiotics show strong antimicro-
bial activity in vitro21 , their ability to protect mice from 
experimental infect ion3 > is somewhat weak because of their 
susceptibility to inactivation by renai DHP. As shown in 
Table 5, imipenem showed no protective activity when it was 
administrated alone at the doses of 0. 4 - 2. 0 mg/kg. In this 
case. no mice survived at day 5 after challenge. But, it 
showed an improved protective actjvity when WS1358Al was co-
administrated with the antibiotic at the combination ratio 
of 1:1. Two and four of five mice were cured at the doses of 
0.4 and 2.0 mg/kg, respectively. The similar result was 
obtained when WS1358Al was replaced by cilastatin. 
Accordingly the improved protective effect of DHP inhi-
bitors in experimental infection related to the augmentation 
of urinary recovery by the inhibitors. 
IV-3 Summary 
The co-administration of WS1358A1 with a carbapenem 
56 -
Table 5. Protective effect of imipenem with or without 





























• ICR mice were intraperitoneally infected with 4 x 108 
Staphylococcus aureus 41. · 
b Drugs were subcutaneously administrated at 1 hour 
after the challenge. 
c Mortalities were determined at day 5 after the 
infection. 
d Co-administration ·at a combination ratio of 1: 1 
(wfw). 
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antibiotic imipenem increased the urinary recovery of the 
antibiotic and improved the protP.ctive effect on experimen-
tal infections. The efficacy of WS1358Al is comparable to 
that of cilastatin 1 • 41 • The author can attribute the in vivo 
effects of WS1358Al to the potent inhibitory activity of the 
compound on DHP by which carbapenem antibiotic is inactiva-
ted. 





Renal DHPs from several species of animal were par-
tially purified by the method described below for porcine 
renal DHP except that procedures following the CNH4)2S04 
precipitation were omitted. 
The effect of WS1358 compounds against the partially 
purified DHPs was measured by a method similar to that used 
for porcine DHP. Moreover, to ascertain the specificity of 
inhibitory activity, the effects of WS1358 compounds against 
mP.tallo-enzymes other than DHP, such as carboxypeptidase A 
(CP~se A) and leucineaminopeptidase (LAP) were determined. 
CPase A was assayed by using carbobenzoxyglycyl-L-phenyl-
alanine as substrate. The activity was determined by obser-
ving the decline in absorbance at 224 nm. LAP was assayed by 
using L-leucine-P-nitroanilide as substrate. The activity 
was determined by observing the decline in absorbance at 405 
nm. Inhibitory effects on the two enzymes were calculated in 
the same manner as those on DHP described in the chapter II. 
Purification of porcine renal DHP 
Purification of DHP from porcine kidney cortex t.o 
apparent homogeneity as judged by SDS polyacrylamide gel 
electrophoresis was carried out using the procedures 
slightly different from those previouly reported 5 - 7 ' . 
The cortex was sliced from the intact kidney and homo-
genized in 25 mM sodium phosphate buffer (pH 8. 0) at 4t in a 
Polytron homogenizer. The homogenate was adjusted to 20~ 
butanol by the addition of butanol which had been chilled 
to -20t. Solubilization of the enzyme was achieved by stir-
ring the mixture at 4t overnight. After dialysis for 24 
hours against several changes of distilled water, the enzyme 
activity was concentrated by precipitation between 50 - 70~ 
(NH4)zS04 . This partially purified enzyme was used to search 
for DHP inhibitors from fermentation broths. Futher purifi-
cation of renal DHP was achieved by means of a HPLC and an 
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affinity column chromatography. HPLC of the CNH4)2S04 frac-
tion was carried out on a TSK SW3000 column using a Waters 
model 6000 HPLC chromatograph with a Waters moel 440 absor-
bance detector and a Hitachi 200 recorder. Affinity column 
chromatogrAphy was performed using a procedure reported by 
Kropp et a1 6 1 • The DHP inhibitor, cilastatin, was coupled to 
cyanogen bromide-activated Sepharose 48 following the manu-
facturer's instruction. The activity of the enzyme at vari-
ous stages of purification was determined by the method des-
cribed below. 
Enzyme kinetic study 
The activity of DHP was determined by measuring the 
rate of enzyme-catalyzed hydrolysis of the unsaturated 
dipeptide glycyldehydrophenylalanine (GOP) at 37t. The fall 
in absorbance of a solution of 5 X 10- 5 M of the peptide 
in 25 mM Tris-HCl buffer (pH 7. 7) was measured at 275 nm. 
Protein concentrations were determined by the method of 
Bradford8 '. Enzyme units are expressed as micromoles of 
substrate hydrolyzed/minute, and specific activity is expre-
ssed as micromoles of substrate hydrolyzed/minute/mg of pro-
tein under the assay condition described above. 
The rates of enzyme-catalyzed hydrolysis of GOP and 
imipenem in the absence or the presence of an inhibitor were 
measured in the similar manner. The enzyme concentrations 
employed in the reactions were 0. 1 ~g/?.. 0 ml for GOP and 44 
~g/2 . 0 ml for imipenem. 
Dertermination of urinary recovery 
For each compound or combination, 3 group of four mice 
were given 1 ml water orally and administrated by intrave-
nous injection. Urine was collected over 0 - 4 hours period. 
Antibiotic concentration in urine samples were determined 
by microbiological assay using Bacillus subtilis ATCC 6633 
against standard of imipenem prepared in 0. 05 M phosphate 
buffer (pH 7). 
6 0 -
Experimental infection 
Female Jcl:ICR mice, 4 weeks of age, were purchased 
from Shizuoka Laboratory AnimAl Center. Hamamatsu, Japan. 
Groups of five mice were intraperitone ally jnjected with lQ H 
Staphylococcus aureus 47 suspended in 5~ mucin solution. 
Combined therapies were subcutaneously administrated at 1 
hour after the infection. Mortalities were determined after 
the observation for 5 days. 
Materials 
CPase A from bovine pancreas (Type II-DEF) and LAP from 
porcine kidney microsomes (Type IV-S) were purchased from 
Sigma Chemical Co. Carbobenzoxyglycyl-L - phenylalanine and 
L-leucine-p-nitroanilide were purchased from Peptide Insti-
tute, Inc., Osaka, Japan. 
GDP!) 1 were synthesized by our chemists . Imipenem and 
cilastatin were purified from Zienam. CNBr-activated Sepha-
rose 48 was purchased from Pharmacia. 
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Chapter V Chemical Transformation and 
Total Synthesis of WS1358Al 
V- 1 Chemical transformation 
Du r i ng t he course of studies on these compounds, we 
found that Al suffe r s chemical transformations to butyro-
lactone A2 (3) and N- hydroxyglutarimide A3 ( 5 ), which are 
r ead ily r econverted t o the original compound Al. As descri-
bed in the chapte r II , these transformations were also found 















WS1358Al ( 1, Na salt) was converted to the free acid by 
t r eatment with Dowex 50WX2 (H+) and lyophilized to give a 
mixture of Al , A2 ( 3 ) and A3 (5) (see Fig. 1 (a) for HPLC 
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5 reverse-phase column (20 mM NH~HzPOA - 1 mM Bu~NOH (pH 
4)), followed by acidification (Dowex 50WX2 CH.)) and p~ri­
fication (Oiaion SP-207 chromatography) gave A2 as free acid 
and A3, after neutralization with 1 N NaOH, as Na salt. When 
treated with an excess of NaOH, A3 was reverted to Al and A2 
to A1 as well via A3 {see Figs. 1 {b) and 1 {c)). 
WS1358A2 (3), C1H!lNOa (FAB-MS, m/z 204 (M.+1)), showed 
an absorption band at 1770 em- 1 in the IR spectrum, suggest-
ing the presence of a T -1 act one system in 3. In the 1 :~ C NMR 
spectrum, 3 exhibited a down-field shift of 5.4 ppm for C-2 
as compared to the corresponding signal in 1 (acylation 
shift)•>. These data suggest that WS1358A2 possesses the 
structure 3. 
WS1358A3 (5), C1HRNOsNa (elemental Analysis); free 
acid, C1HnNOr. (FAB-MS, m/z 204 (M.+l)), showed carbonyl 
bands at 1730 and 1670 em-• in addition to 1630 cm- 1 {carbo-
xylate) in the IR spectrum of the Na salt, suggesting t,he 
p~esence of a N-hydroxyglutarimide function in 5. Hence the 
structure of WS1358A3 was assigned to be 5. 
Transformation of the A series of compounds is summa-
rized in Fi~ 2 . On treatment with 0. 5 N NaOH (1 minute), A2 
(3) was cyclized to A3 (5), which in turn was exposed to a 
prolonged treatment with the same alkaline medium (e.~ 20 
minutes) to give Al (1) . A similar treatment of A3' (0. 5 N 
NaOH, 20 minutes) gave Al' as well. As shown in Fig. 2, A3' 
might be converted into A1' via A2' (corresponding to t.he 
diastereoisomer of A2) which could not be isolated in the 
- 6 5 -
Fig. 2. Proposed pathway of chemical transformation of WSl358A series. 
OH- (20 minutes) 
/ (pure) ~ 
A 1 ( 1) H+ A2 ( 3) + A3 (5) 
A 11 
'\ OH- ( 1 minute) I 
H+ 
A2' (not isolated) + A3' 
""' 
OH- (20 minutes) / 
(pure) 
Fig. 3. Chemical transformation of natural WS1358B 
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synthesjs describect above. 
The minor product 81 (2) from the natural source was 
found to show a similar behavior. Thus, after acidification 
with Dowex 50WX2 (H.), 81 was lyophilized to give 82 (4) and 
83 (6) together with 81 unchanged (see Fig. 4). Isolation of 
82 and 83 was performed by a procedure similar to that used 
for the A series of compounds. 
WS1358B2 showed an IR absorption band at 1780 cm- 1 , 
indicating the r-lactone structure 4 for 82, while the IR 
spectrum of 83 showed, in addition to 1680 cm- 1 (carboxylic 
acid), carbonyl bands at 1730 and 1640 cm- 1 which were 
assignable to the carbonyls of the N-hydroxyglutarimide 
structure, leading to the structure 6 for 83. The other 
physical data of 82 and 83 are recorded in Experimental. On 
treatment with 0. 5 N NaOH, 82 and 83 showed a behavior 
similar to those of A2 and A3, respectively, and finally the 
two compounds reverted to 81 (2). 
Each product of both A and 8 series was thus chemically 
characterized and, fortunately, the synthetic route descri-
bed above was amenable for obtaining stereoslectively the 
major natural product Al although its stereochemistry 
remained equivocal. 
The biological activities of the products described 
above are summarized in comparison with those of the natural 
A1 (1) and 81 (2) in Table l. The activit.ies of. the natural 
A2 (3) and A3 (5) were considerably less than that of A1 and 
this was the case of the 8 series of products. The synthetic 
6 7 -
compounds Al, A2, A3 and 81 (all racemates) were approxi-
mately 2-fold less active than the corresponding natural 
products, respectively. The diastereoisomer Al' and A3' were 
considerably less active even when compared with the synthe-
tic Al and A3, respectively. 
Table 1. Inhibitory actlvtty (IC, 0) of synthetic and 




AI (1) 1.5 0.83 
Al' 230 nd 
A2 (3) 16 10 
A3 (5) 78 45 
AJ' 4,300 nd 
Bl (2) 340 150 
B2 (4) nd 2,000 
B3 (6) nd > 10,000 
nd: Not determined. 
V-2 Total synthesis of WS1358Al 
The author found in the conversion of A3 to Al that the 
hydrolysis was regiospecific to yield Al almost as a single 
product and, therefore, we anticipated that a stereoselec-
tive synthesis of A3 could be entirely corresponding to a 
regio- and stereoselective synthesis of AI. Thus, I under-
took the synthesis of Al accordjng to the synthetic route 
- 6 8 -
outlined in Fig. 4. I envisioned that, in this synthesis, 
the cycli7.ation of 11 to 12 would proceed thermodynamically, 
resulting in a stereoselective synthesis of 12. Hydrolysis 
of 12 would then stereoselectively afford the final product 
1 (racemate) as described above, although it was ambiguous 
at that time whether the desired configuration would be 
obtained. 
The starting material 7, prepared by Michael condensa-
tion2>of benzyl crotonate and diethyl malonate, was hydroge-
nolysed and the resulting carboxylic acid 8 was chlorinated 
with NaOCl to give chlori de 9. Activation of the carboxylic 
acid in 9 with N-hydroxysuccinimide and dicyclohexylcarbo-
diimide, followed by treatment with hydr.oxylamine produced 
a mixutere of hydroxamic acid 11 and N-hydroxyglutarimide 12 
together with other minor products. Tt was clear that , in 
the above reactions, 12 was formed by cyclization of 11 (see 
below for a corroborative evidence). The separation of 11, 
12, and the minor produ8ts at this stage was found to be 
difficult, because 11 was partially ryclized to 12 during 
the period of purification by chromatography on silica gel. 
Therefore, the mixture was directly subjected to the next 
reaction and treated with 1 N NaOH. The reaction mixture was 
acidified using Dowex 50WX2 (H+) and lyophilized to give a 
crude mixture. which was applied to a DiaJon SP-207 column 
chromatography to give pure A3 (5, racemate) as the first 
eluent. Later fractions containing A2 and the minor products 



























ic!lowed by preparative HPLC (YMC ODS-5) to give a partially 
purifiP.d A2 (3) and one of the minor products. The product 
A2 was treRted with Dowex 50WX2 {H•) and followed by further 
purification by Diaion SP-207 chromatography and lyophili-
zation to afford A2 (3, racemate). The minor product iso-
lated as above was also purified jn a similar manner and, 
after neutralization to pH 6 with 1 N NaOH, lyophilized to 
give pure product A3 ' (see Fig. 2). The spectral data of A3' 
was quite similar to those of A3 (fi), revea l ing that A3' is 
a diastereoisomer of A3. The ratio of A3 and A3' just after 
the hydrolysis of 11 and 12 was about 5 : 1 on HPLC. 
V-3 Surrunary 
The structures of compounds 3 (~nd 4) and 5 (and 6) 
derived from the natural products WS1358Al (1) (and 81 (2)) 
have been determined by their spectroscopic evidence. HPLC 
analyses clarified the pathway of the transformation. By 
taking advantage of these transformations, an improved syn-




IR spectra were recorded on a Jasco A-120 spectrometer. 
1 H and 13 C NMR spectra were measured on a Bruker AM400 spec-
trometer. Mass spectra were detP.rmined with a VG ZAB-SE 
spectometer. Analytical HPLC was performed on a Hitachi 655 
liquid chromatography using a YMC ODS-5 column (4. 6 X 250 
mm) and preparative HPLC was 0.arried out using a YMC OOS-5 
column (20 X 250 mm). 
WS1358A2 (3) and A3 (5) 
WS 13 5 8A 1 (1, N a sa 1 t, 1 0 0 mg) was d i s so l ved i n water 
(2 ml) and passed through a column of Oowex 50WX2 (H•, 3 ml) 
and eluted with water (10 ml). The eluate was adjusted to 
pH 1. 8 with 6 N HCl and lyophilized to give a powder (76 mg. 
see Fig. 1 (a) for HPLC analysis). Preparative HPLC of this 
mixture was carried out on YMC OOS-5 using a buffer of 20 mM 
NH~H2P04- 1 mM Bu4NOH (pH 4) as eluant. The fraction con-
tainig A2 was purified by chromatography on Oiaion SP-207 
(7. 5 ml) eluting with water and the eluate was passed 
through a column of Oowex 50WX2 (H~. 7 ml) and eluted with 
water. The eluate was lyophilized to give A2 (3, 24 mg) as 
the free acid: FAB-MS, m/z 204 (M~ +1); IR (K8r) em- 1 1780-
1640 (broad); 1 HNMR (020) 6 3 . 16 (1H.m), 2.87 (lH, dd, J= 
18 and 8. 5 Hz), 2. 49 (lH, dd, J = 18 and 8 Hz), 1. 23 (3H, d, 
J=7Hz); 13 CNMR (020) 6180.6 (s), 171.8 (S), 168.6 (S), 
91.2 (s), 39.6 (d), 37. 7 (t), 17.9 (q). 
The Na salt of A2 was prepared by neutralization of a 
solution of the free acid in water to pH 7 with 1 N NaOH and 
subsequent lyophilization: IR (KBr) em-' 1770, 1650, 1600; 
1 H NMR (0 2 0) 6 3. 08 (lH, m), 2. 82 (lH, dd, J = 18 and 8 Hz), 
2. 40(1H, dd, J = 18 and 7 Hz), 1.15 (3H, d, J = 7 Hz); 1 3 C 
NMR {0 2 0) 6181.9 (s), 174.4 (s) , 170.4 (s), 93.4 (s), 38.9 
(d), 38. 5 (t), 18.4 (q). 
The fraction containing A3 on the preparative HPLC was 
similarly purified. The eluate obtained by a Oowex 50WX2 
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col\~n chromatography was neutralized to pH 7 with 1 N NaOH 
and lyophilized to give A3 (5, 32 mg) as the Na salt: IR 
(K8r-) em-• 1730, 1670, 1630; 1 H NMR (0 2 0) o 2.86 (1H, dd, J 
= 17.5 and 5Hz), .2. 76 (lH, dd, J = 17.5 and 9. fi Hz), 2. 62 ( 
lH, m), 0.97 (3H, d, J = 6.5 Hz); 13 C NMR (0 2 0) o 177. 4 (S), 
174.2(s), 173.9 (s), 83.0 (s), 38.6 (t), 34.5 (d), 15.9 (q). 
The free acid was prepared by treatment of a solution 
of the Na salt in water with Dowex 50WX2 (H~) and subsequent 
lyophilization: FAB-MS, m/z 204 (M.+l); !R (K8r-) em-• 1720-
1620 (broad) ; 1 H NMR (0 2 0) o 2. 83 (lH, dd, J = 17 and 5 Hz), 
2 . 83-2. 65 (2H, m), 0. 96 (3H, d, J = 7 Hz) ; 1 3 C NMR (0 2 0) 6 
175.5 ( s) , 173.4 (s) , 171.9 (s) , 82 . 3 (s), 38.0 (t) , 34.4 
(d), 15.6 (q). 
WS135882 (4) and 83 (6) 
Compounds 82 and 83 were obtained in a manner similar 
to that for A2 and A3 as the free acids. For HPLC analysis, 
see Fig. 4. 82 (4): FA8-MS, m/z 190 (M.+1); IR (K8r) em- 1 
1780, 1730, 1680; 1 H NMR (D:tO) o 2. 80-2 . 71 (4H, m); 13 C NMR 
(DzO) 1 181.1 (s) , 173.2 (s), 168.9 (s), 88.6 (s), 31.9 (t) , 
30. 1 (t) . 83 (6): FA8-MS, m/z 190 (M.+l) ; 1 H NMR (0 2 0) 6 
3.04-2.88 (2H, m), 2.45 (lH, m), 2.26 (1H, m); 13 C NMR (DzO) 
o 175.1 (s), 173.8 (s), 172.3 (s), 79.3 (s), 31.0 (t) , 30.0 
( t). 
Conversion of A2 (3) to Al (1) via A3 (5) 
A sample (5 mg) of 3 (free acid) was dissolved in 0. 5 N 
NaOH (5 ml) and, after 1 minute, the solution was analyzed 
using HPLC. After being left at room t.emperat.ure for 20 
minutes , the solution was again subjected to HPLC analysis. 
The data were shown in Fig. 1 (b). 
Conversion of A3 (5) to Al (1) 
A sample (5 mg) of 5 (free acid) was dissolved in 0. 5 N 
NaOH (5 ml) and, after being left at room temperature for 1 
and 20 minutes subjected to HPLC analysis. The data were 
shown in Fig. 1 (c). 
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Benzyl 4,4-Diethoxycarbonyl-3-methylbutyrate (7) 
A solution of diethyl malonate (8. 16 g, 0. 051 mol) in 
benzene (30 ml) was added to a suspension of sodium hydride 
(60~ dispersion in mineral oil, 0. 2 g, 5 mmol) in benzene 
(30 ml) under nitrogen atmosphere. After the evolution of 
hydrogen ceased, a solution of benzyl crotonate (9 g, 0.051 
mol) in benzene (30 ml) was added to the above mixture. The 
mixture was refluxed for 15 hours and, after cooling to room 
temperature, the reaction mixture was poured into ice water 
(200m!). The organic layer was separated and the aqueous 
layer was extracted with ether. The benzene and ether layers 
were combined, washed with water, and dried over MgS04. 
Filtration and evaporation gave a crude product (17 g) which 
was further evaporated under reduced pressure (2 mmHg) to 
give 7 as the residue: El-MS, m/z 336 (M•); 1 H NMR (CDCl3) 
6 7 . 35 (5H, m) , 5. 12 (2H, s), 4.19 (4H, q, J = 7 Hz), 3. 41 
(lH, d, J = 7 Hz), 2. 75 (lH. m), 2. 61 (lH, dd, .J =16 and 5 
Hz) , 2. 37 (lH, dd, J = 16 and 8. 5Hz), 1. 26 (6H, t, J = 7 
Hz), 1. 08 (3H, d, J = 7 Hz). 
4, 4-Diethoxycarbonyl-3-methylbutyric Acid (8) 
A solution of 7 (3 . 36 g, 0. 01 mol) in dioxane (50 ml) 
was hydrogenated over 10~ Pd-C (0. 5 g) under 5 atm pressure 
of hydrogen. After removal of the catalyst by filtration, 
the filtrate was concentrated to give an oily residue (2. 43 
g), which was purified by chromatography on silica gel (60 
g) eluting with 5~ methanol in chloroform to give 8 as an 
oil (2. 11 g): EI-MS, m/z 247 (M.+1); 1 H NMR (CDC13) 6 4. 21 
(4H, q, J =7Hz), 3. 42 (lH, d, J = 7Hz), 2. 76 (lH, m), 
2. 64 (lH, dd, J = 16 and 5 Hz) . 2. 38 (lH, dd, J = 16 and 8. 5 
Hz), 1. 28 ( 6H, t, J = 7 Hz), 1. 11 ( 3H, d, J = 7 Hz). 
4-Chloro-4,4-diethoxycarbonyl-3-methy1butyric Acid (9) 
NaOCl (available chlorine 5~ minimum, 25 ml, 0. 017 mol) 
was added dropwise (30 min) to a solut]on of 8 (3. 69 g, 
0.015 mol) in water (50 ml) with stirring under room tempe-
- 74 -
Benzyl 4,4-Diethoxycarbonyl-3-methylbutyrate (7} 
A solution of diethyl malonate (8. 16 g, 0. 051 mol} in 
benzene (30 ml) was added to a suspension of sodium hydride 
(6096 dispersion in mineral oil, 0. 2 g, 5 mmol} in benzene 
(30 ml) under nitrogen atmosphere. After the evolution of 
hydrogen ceased, a solution of benzyl crotonate (9 g, 0. 051 
mol) in benzene (30 ml} was added to the above mixture . The 
mixture was refluxed for 15 hours and, after cooling to room 
temperature, the reaction mixture was poured into ice water 
(200ml}. The organic layer was separated and the aqueous 
layer was extracted with ether. The benzene and ether layers 
were combined, washed with water, and dried over MgS04. 
Filtration and evaporation gave a crude product (17 g) which 
was further evaporated under reduced pressure (2 mmHg) to 
give 7 as the residue: EI -MS, m/z 336 (M+) ; 1 H NMR (CDCl3) 
o 7.35 (5H, m), 5.12 (2H, s), 4.19 (4H, q, J= 7Hz), 3.41 
(lH, d, J = 7 Hz). 2. 75 (lH, m). 2. 61 (lH, dd, .J =16 and 5 
Hz), 2. 37 (lH, dd, J = 16 and 8 . 5Hz). 1. 26 (6H, t, J = 7 
Hz), 1. 08 (3H, d, J = 7 Hz). 
4,4-Diethoxycarbonyl-3-methylbutyric Acid (8) 
A solution of 7 (3.36 g, 0. 01 mol) in dioxane (50 ml) 
was hydrogenated over 1096 Pd-C (0. 5 g) under 5 atm pressure 
of hydrogen. After removal of the catalyst by filtration, 
the filtrate was concentrated to give an oily residue (2.43 
g) , which was purified by chromatography on silica gel (60 
g) eluting with 596 methanol in chloroform to give 8 as an 
oil (2.11 g) : El-MS, m/z247 (M.+1); 1 HNMR (CDC13) o 4.21 
(4H, q, J = 7 Hz), 3. 42 (lH, d, J = 7 Hz), 2. 76 (lH, m), 
2.64 (lH, dd, J = 16 and 5Hz), 2.38 (lH, dd, J = 16 and 8.5 
Hz), 1. 28 (6H, t, J =7Hz), 1.11 (3H, d, J = 7Hz}. 
4-Chloro-4,4-diethoxycarbonyl-3-methylbutyric Acid (9} 
NaOCl (available chlori ne 596 minimum, 25 ml, 0. 017 mol} 
was added dropwise (30 min) to a solution of 8 (3. 69 g, 
0. 015 mol} in water (50 ml) with stirring under room tempe-
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rature. The pH of the mixture was reached to 7. 0. After 
stirring for an additional 30 minutes, the reaction mixture 
was acidified to pH 2.0 with 1 N HCl and extracted with 
ether. The extract was washed with water, dried over MgS01 
and evaporated to give a crude oil, which was purified by 
chromatography on silica gel (150 g) elu t ing with 5~ metha-
nol in chloroform to give 9 as an oil (3. 56 g): FAB-MS, m/z 
281, 283 (M.+1); IR (CHCl:d cm- 1 1740, 1710; 1 H NMR (CDC13) 
6 4.30 (2H, q, J =7Hz), 4.29 (2H, q, J =7Hz), 3.14 (lH, 
m), 2. 87 (lH, dd, J = 16. 5 and 2. 5 Hz), 2. 33 (lH, dd, J = 
16.5andl0Hz), 1.31 (3H, t, J=7Hz), 1.29 (3H, t, J=7 
Hz), 1.12 (3H, d, J =7Hz). 
4-Chloro-4,4-diethoxycarbonyl-3-methylbutyric Acid Suc-
cinimide Ester (10) 
To a mixture of 9 (2. 81 g, 10 mmo 1) and N-hydroxy-
succinimide (1. 15 g, 10 mmol) in methylene chloride (50 ml) 
was added dicyclohexylcarbodiimide (2.06 g, 10 mmol) and the 
mixture was stirred at room temperature for 15 hours . After 
removal of the precipitate by filtration, the filtrate was 
concentrated to give 10 as a crude oil (2. 96 g), which was 
used for the next reaction without purification: 1 H NMR 
(CDC13) 6 4. 30 (2H, q, J = 7 Hz), 4. 29 (2H, q, J = 7 Hz), 
3.13 OH, m), 3 . 10 OH, dd, J= 16.5 and 2 . 5 Hz), 2 . 85 (4H, 
s), 2.59 (lH, dd, J=l6.5andl0Hz), 1.30 (3H, t, J=7Hz 
), 1. 29 (3H, t, J =7Hz), 1.15 (3H, d, J =7Hz). 
Diethyl 2-Chloro-2-((2-hydroxyaminocarbonyl-1-methyl) 
ethyl)malonate (11) and Ethyl 3-Chloro-1-hydroxy-4-methyl-
2,6-dioxo-3-piperidinecarboxylate (12) 
A solution of hydroxylamine hydrochloride (834 mg, 12 
mmol) in water (10 ml) was, after neutralizaion by adding 
1 N NaOH (15 ml), added to a solution of 10 (2. 96 g, 10 
mmol) in ethanol (30 ml) with stirring at Ot. The mixture 
was stirred at room temperature for 5 hours and at 80t for 2 
hours. The reaction mixture was acidified to pH 2 with 1 N 
HCl, diluted with water (150 ml), and extracted with ethyl 
- 7 5 -
acetate. The extract was washed with water, dried over 
MgS04, and evaporated to give a crude mixture (2. 7 g), which 
was purified by chromatography on silica gel (90 g) eluting 
with 5% methanol in chloroform to give a mixture of 11 and 
12 (1.78 g). A 100 mg sample of this mixture was subjected 
to a preparative TLC (silica gel plate, 0. 5 mm) developing 
with 10% 2-propanol in benzene to give 11 (44 mg, oil) and 
12 ( 45 mg, oil). 11 (major diastereoisomer): FAB-MS, m/z 
296, 298 (M.+l) and 318, 320 (M.+Na); IR (CHC1 3 ) em- 1 1740, 
1665; 1H NMR (CD:~OD) 6 4. 28 (4H, q, J = 7Hz), 3 .1 0 (lH, m), 
2. 47 (lH, dd, J = 14 and 2. 5 Hz), 2. 03 (lH, dd, J = 14, 11 
Hz), 1. 29 (6H, t, J =7Hz), 1. 04 (3H, d, J = 7 Hz). 12 
(major diastereoisomer): FAB-MS, m/z 250, 252 (M.+l) and 
272, 274 (M.+Na); IR <CHCl:~) em- 1 1750, 1695; 1 H NMR (CD:~OD) 
o 4. 35 (2H, q, J =7Hz), 3.11 (lH, m), 2. 82 (2H, m), 1. 31 
(3H, t, J =7Hz), 1.04 (3H, d, J =7Hz); 13 C NMR (CD30D) 
6 168. 2, 166. 3, 165. 3, 75. 2, 64. 9, 37. 1, 34. 0, 14. 7, 14. 2. 
Alkaline treatment of 11 and 12 
A mixture of 11 and 12 (400 mg) was dissolved in 1 N 
NaOH (8 ml) and stirred at room temperature for 3 hours. 
After neutralization to pH 7 with 1 N HCl, the mixture was 
analyzed by HPLC using a column of YMC ODS-5. The data were 
shown in Fig. 5 (a). The ratio of AI {1) and its diastereo-
isomer was about 5 : 1. 
The mixture obtained above was acidified by passing 
through a column of Dowex 50WX2 {H+, 6 ml) eluting with 
water and the eluate was lyophilized to give a crude product 
containing Al, A2, A3, and their diastereoisomer {324 mg ). 
This mixture was applied to a column of Diaion SP-207 {60 
ml) eluting with water. The fractions containing A3 only 
were lyophilized to give pure A3 (5, racemate, 97 mg): The 
IR, 1H and 13 C NMR spectra and the retention time on HPLC 
were all identical with those of the natural product. 
The fractions containing A2 and A3' mainly were lyophi-
lized to give a mixture of A2 and A3' (105 · mg), which was 
subjected to preparative HPLC on YMC ODS-5 eluting with a 
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Fig. S. Chemical transformation ai synthetic WS-
1358A series: HPLC analysis. 
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buffer of 20 mM NH,H2Po~- 1 mM Bu~NOH (pH 4) at a flow rate 
of 5. 0 ml/minute. The fraction containing A2 was concent-
rated to give a crude product of A2 (42 mg), which was aci-
dified by a Dowex 50WX8 (H•) column (10 ml) eluting with 
water and the eluate was concentrated to about 2 ml. This 
concentrate was purified by chromatography on Diaion SP-207 
(7 ml) eluting with water and the eluate was lyophilized to 
give A2 (3, racemate, 32 mg): theIR, 1 H and 13 C NMR and 
the retention time on HPLC were a~ l identical with those of 
the natural product. 
The fraction containing A3' on the preparative HPLC 
described above was concentrated to give a crude product of 
A3' (20 mg), which was purified in a similar manner using 
Dowex 50WX8 and Diaion SP-207. The fraction of the final 
Diaion SP-207 chromatography was adjusted to pH 6. 2 (1 N 
NaOH) and lyophilized to give A3' (the diastereoisomer of 
A3, racemate, 16 mg): IR (KBr) em- 1 1680, 1640; 1 H NMR 
(DzO) 6 2. 87 (2H, d, J = 9Hz), 2. 39 (lH, m), 1. 00 (3H, d, 
J = 6.5 Hz); 13 C NMR (D:oO) o 175 . 5 (s), 174.5 (s), 174.4 
(s), 83.5 (s), 39.3 (t), 35.4 (d), 16.8 (q). 
WS1358A1 ( 1, racemate) 
A sample (500 mg) of the synthetic compound A3 (5, 
racemate) was dissolved in 0. 5 N NaOH (10 ml) and allowed to 
stand for 3 hours at room temperature, the solution was then 
neutralized by passing through a column of Dowex 50WX2 (H•, 
6 ml) eluting with water. The eluate was subjected to 
chromatography on DEAE-Toyopearl (Cl-, 45 ml) eluting with 
0.02 M NaCl solution and the eluate was concentrated and 
adjusted to pH 2. 0 with 6 N HCl . The concentrate was further 
purified by chromatography on Diaion SP-207 (60 ml) eluting 
with water and the eluate was neutralized to pH 7 with 1 N 
NaOH, then lyophilized to give Al (1, racemate, Na salt, 
213 mg): The IR, 1 H NMR, 13 C NMR spe-ctra and the retention 
time on HPLC were all identical with those of the natural 
product . 
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Diastereoisomer Al' (racemate) of WS1358Al 
A sample (20 mg) of A3' (racemate) described above was 
treated with 0. 5 N NaOH in a manner similar to that for the 
conversion of A3 to Al, giving pure Al' (racemate, Na salt, 
9mg): IR (KBr) cm- 1 1650, 16?.0: 1 HNMR (0 2 0) 6 2.76 (lH, 
m), 2. 08 (lH, dd. J = 14 and 3 Hz), 1. 99 (lH. dd, J = 14 and 
11Hz), 0.87 (3H, d, J= 6.5 Hz); 1 :~CNMR (0 2 0) 6184.5 (s), 
177.6 (s), 173.2 (s), 86.0 (s), 41.9 (t), 38.9 (d), 16.0 
(q). For HPLC analysis, see Fig. 5 (b). 
HPLC analysis 
A Model 635 Hitachi liquid chromatograph was used in 
this study. A 15-cm TSK gel ODS 80TM column was used with a 
mobile phase consisting of 0.2 M NH4H2P01 (pH 4) containing 
1 mM Bu1NOH for WS1358A compounds. A 25-cm YMC ODS-5 column 
was used with a mobile phase of 0. 1~ TFA for WS1358B 
compounds. The flow rate was 1 ml/minute and solutes were 
detected by UV (210 nm). The retention times of A1, A2, A3, 
Al' and A3' were 7. 15, 10. 35, 19. 55, 8.13 and 14.75 minutes, 
respectively. Those of 81, 82 and 83 were 3. 73, 3. 98 and 
4 . 29 minutes, respectively. 
Biological evaluation 
Inhibitory activity (IC5o) of the compounds described 
above against porcine DHP was measured by the method descri-
bed in the preceding chapter. 
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Chapter VI Conclusion 
Renal dipeptidase, dehydropeptidase-I (DHP, EC. 3. 4. 13. 
11.) hydrolyzes the ~ -lactam ring of the carbapenems which 
are e. new class of structurally novel ~ -lactam antibiotics. 
The low recovery of the carbapenems in the urine of labora-
tory animal and the low efficacy against experimental infec-
tjon arc attributed to the metabolism of the antibiotics by 
DHP. 
Cilastatin, an inhibitor of DHP, was synthesized by 
Merck's researchers and has been clinically used in a new 
combination antimicrobial imipenem/cilastatin. In this com-
bination, cilastatin has been proved to be effective in pro-
tecting imipenem, a derivative of thienamycin, from hydroly-
sis by DHP and restoring imipenem urinary . recovery in human 
as well as in experimental animals. 
No specific inhibitor against DHP other than cilastatin 
has been yet reported. During our screening program search-
ing for novel enzyme inhibitors, the author found specific 
inhibitors against DHP, designated WS1358Al and Bl, from the 
fermented broth of Streptomyces parvulus subsp. tochigiensis 
No. 1358. The structure of WS1358Al and Bl have been establ i-
shed to be 2-hydroxy-2-hydroxyaminocarbonyl-3-methylglutaric 
acid and 2-hydroxy-2-hydroxyaminocarbonylglutaric acid, res-
pectively, on the basis of spectroscopic evidence and syn-
thesis of the racemates. 
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To ascertain the pos sibility t hat WS 1358Al c an be used 
as a counterpart in a combination therapy, a preliminary 
pharmacological evaluation in experimental animals was car -
r ied out. 
The co- administration of WS1358Al with a carbapenem 
antibiotic imipenem increased the urinary recovery of the 
antibiotic and improved the protective effect on experimen-
tal infection. The efficacy of WS1358Al are comparable to 
that of cilastatin. The author can attribute the in vivo 
effects of WS1358Al to the potent inhibitory activity of the 
compound on DHP by which carbapenem antibiotic is inactiva-
ted. WS1358Al should be considered in a combination therapy 
with carbapenem antibiotics like imipenem/cilastatin. 
During the course of studies on these compounds, the 
author found that Al suffers chemical transformations to 
butyrolactone A2 and N- hydroxyglutarimide A3, which are rea-
dily converted to the original compound Al. These transfor-
mations were also found to expedite the purification of this 
series of natural products and a practical synthesis of 
WS1358Al (racemate) . 
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